December 2019 - Page 5 of 6

FridayDec 06, 2019 3:01 pm

ChineseInvestors.com Inc. (CIIX) CEO Sees Untapped Potential for CBD in China’s Market, Speaks to Stock Fluctuation

CIIX CEO Warren Wang and CBD Biotech executives attended 2019 China Industrial Cannabis CBD Industry International Conference At well over one billion people, China’s cannabis industry market potential is four times the size of America’s CEO responds to stock’s fluctuating volatility, urges shareholders to continue to invest ChineseInvestors.com Inc. (OTCQB: CIIX) is a leading purveyor of financial information and education for Chinese-speaking investors in the United States and China providing real-time market commentary, analysis, and educational-related services in Chinese character language sets. The products and services offered help investors make informed decisions and meet individualized financial goals. After creating inroads…

FridayDec 06, 2019 11:22 am

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Unveils Full-Spectrum CBD Oil

SPRWF launches Pūr Dew, an exclusive, full-spectrum CBD oil available under company’s wellness-focused brand, Blissco New product part of company’s strategic entry into one of the fastest-growing product segments Initially available in British Columbia, new product expected in other provinces in coming months The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of cannabis companies, has launched its newest product – Pūr Dew, an exclusive, full-spectrum CBD oil available under the company’s wellness-focused brand, Blissco (http://cnw.fm/G4tkm). The product marks a milestone for Supreme Cannabis Company as it enters the CBD market; current SPRWF products include…

FridayDec 06, 2019 9:00 am

Can CBD Help You Cure Type 2 Diabetes?

The list of conditions that cannabidiol can cure is apparently endless. For the past few years, people have been turning to the hemp extract to manage everything from anxiety and insomnia to chronic pain and high blood pressure. There's even a CBD-based drug approved by the U.S. Food and Drug Administration (FDA) to treat rare and hard to manage pediatric epilepsies. It seems like Type 2 diabetes just might be on the list too. Kevin Simpson, founder of online CBD retailer OilsBySimpson, suffered from a myriad of medical conditions before he discovered cannabidiol. In 2009, he was suffering from anxiety…

ThursdayDec 05, 2019 4:00 pm

How Many Drops of Cannabidiol Bring Pain Relief?

Let's talk a little about cannabidiol (CBD). You have undoubtedly heard of the hemp extract, famous as it is these days. The cannabidiol market was already worth at least one billion by the end of 2018, and experts say it could grow to more than $20 billion by 2026. Last year, CBD gummies were the third most searched for food in the United States. Packed with potent and versatile medicinal properties, cannabidiol is said to be effective against anxiety, insomnia, high blood pressure, and a myriad of other diseases. But perhaps, CBD's most common use, at least in the U.S.,…

ThursdayDec 05, 2019 12:54 pm

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces New VP to Lead Sales Operations

SPRWF welcomes new senior vice president of commercial to executive team Joel Toguri to advance and oversee company’s provincial, retail sales operations across all brands New VP has two decades of experience spanning the cannabis, alcohol beverage, and apparel industries The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of cannabis companies, has announced the appointment of a new senior vice president of commercial (http://cnw.fm/XWt6G). With more than two decades of regulated industry expertise under his belt, including experience working in the cannabis space, Joel Toguri is well suited to further strengthening the SPRWF executive…

ThursdayDec 05, 2019 11:56 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Makes Edible Drug Delivery Platform Even Faster

Lexaria Bioscience is a company that is passionate about establishing alternatives to inhalation for rapid-response drug substance delivery in order to eliminate the lung harm that smoking or vaping may cause Lexaria’s DehydraTECH platform has generated numerous patents with more pending as a way to provide quick substance delivery to the user’s bloodstream and better access through the blood-brain barrier Lexaria recently announced it had further improved DehydraTECH, as demonstrated in testing that showed early pilot-stage human trial participants began to note edible THC effects in under 10 minutes – more rapidly than the previous DehydraTECH formulation Prior technology testing…

ThursdayDec 05, 2019 9:00 am

UCSD Researchers Study Possible Benefits and Risks of Cannabidiol

Cannabidiol (CBD) has achieved what very few products have. From being barely known, CBD has grown so quickly that it is estimated the cannabidiol market will be worth at least $20 billion in sales by 2026. However, there's a good reason why most new products have to go through a lengthy approval period before hitting the shelves. Especially products that claim to cure a variety of diseases. Given the sheer amount of CBD products on the market right now, estimated to be in the thousands, one would think that regulatory authorities have properly vetted and approved them. The truth is,…

WednesdayDec 04, 2019 4:00 pm

How Long Can CBD Last Before Going Bad?

Cannabidiol (CBD) is all the rage these days. From a compound that was almost unknown three years ago, it has grown into an industry worth billions, and it's expected to grow even bigger in the coming years. The hemp extract's popularity is due to its ability to work against a wide variety of medical conditions. The list is almost unending, and it includes anxiety, high blood pressure, and chronic pain. There's even a CBD-based drug approved by the U.S. Food and Drug Administration (FDA) to treat seizures in severe and hard to manage pediatric epilepsies. But, does cannabidiol go bad?…

WednesdayDec 04, 2019 2:19 pm

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Drug Delivery Platform Proven to Enhance Absorption of Bioactive Compounds

DehydraTECH™ is patent protected for multiple Active Pharmaceutical Ingredients (APIs) including hemp oil CBD and cannabis, nicotine, non-steroidal anti-inflammatory drugs, and fat-soluble vitamins Lexaria has 16 patents granted and over 60 patent applications pending worldwide DehydraTECH™ shown to facilitate rapid uptake and highly targeted delivery of pharmaceuticals to the brain Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is accelerating its patented DehydraTECH based drug delivery technology and formulation development. Funding received from the first tranche of Lexaria’s previously announced private placement of units, issued at a price of $0.45 per unit, realized gross…

WednesdayDec 04, 2019 1:23 pm

No Borders Inc. (NBDR) Launches Revolutionary Blockchain-Based ‘CBD LabChain’ to Deliver Secure, Transparent and Verified Lab Results

CBD LabChain is the all new blockchain data security platform crafted to provide CBD brands with a transparent, immutable certification of CBD lab test results No Borders Labs believes CBD LabChain offers a powerful tool to overcome common consumer concerns regarding trying or using hemp-derived CBD products No Borders continues its early filing tradition as a listed company on the OTC Market, reporting another record quarter of revenue growth No Borders Inc. (OTC: NBDR), a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting edge technologies to reduce costs while increasing revenues…

News and publishing service for CBD related companies

Contact us: 303.498.7722

Month: December 2019